Interleukin-1 induces lipid peroxidation and membrane changes in rat hippocampus: An age-related study

Gerontology

Volumn 45, Issue 3, 1999, Pages 136-142

  Murray, C A ^a   Clements, M P ^b   Lynch, M A ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b OPEN UNIVERSITY   (United Kingdom)

Author keywords

Aging; Arachidonic acid; Hippocampus; Interleukin 1 ; Lipid peroxidation; Reactive oxygen species

Indexed keywords

ALPHA TOCOPHEROL; ARACHIDONIC ACID; CALCIUM CHANNEL; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA;

AGING; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HIPPOCAMPUS; IMMUNITY; LIPID PEROXIDATION; MALE; MEMBRANE; NERVE CELL; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; RECEPTOR DENSITY;

AGING; ANIMALS; ARACHIDONIC ACID; BRAIN CHEMISTRY; CELL MEMBRANE; HIPPOCAMPUS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; LIPID PEROXIDATION; MALE; NEURONS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SIALOGLYCOPROTEINS; VITAMIN E;

EID: 0032927888     PISSN: 0304324X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000022076     Document Type: Article

References (42)

1. Sapolsky R, Rivier C, Yamamoto G, Plotsky P, Vale W: Interleukin-1 stimulates the secretion of hypothalamic corticotrophin-releasing factor. Science 1987;238:522-524.
2. Hopkins SJ, Rothwell NJ: Cytokines and the nervous system, I: Expression and recognition. Trends Neurosci 1995;18:83-88.
3. Terao A, Oikawa M, Saito M: Tissue-specific increase in norepinephrine turnover by central interleukin-1, but not by interleukin-6, in rats. Am J Physiol 1994;266:R400-R404.
4. Zalcman S, Green-Johnson JM, Murray L, Nance DM, Dyck D, Anisman H, Greenberg AH: Cytokine-specific central monoamine alterations induced by interleukin-1, -2, and -6. Brain Res 1994;643:40-49.
5. Banks WA, Kastin AJ, Durham DA: Bidirectional transport of interleukin-1 alpha across the blood brain barrier. Brain Res Bull 1989; 23:433-437.
6. Coceani F, Lees J, Dinarello CA: Occurrence of interleukin in cerebrospinal fluid of the conciouscat. Brain Res 1988;446:245-250.
7. Ferriera SH, Lorenzetti BB, Bristow AF, Poole S: Interleukin-1β as a potent hyperalgesic agent antagonized by a tripeptideanalogue. Nature 1988;334:698-700.
8. Yao J, Keri J, Taffs RE, Colton CA: Characterization of interleukin-1 production by microglia in culture. Brain Res 1992;591:88-93.
9. Griffin WST, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, White CL III, Araoz C: Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 1989; 86:7611-7615.
10. Lechan RM, Toni R, Clark BD, Cannon JG, Shaw AR, Dinarello CA, Reichlin S: Immuno-reactive interleukin-1b localization in the rat forebrain. Brain Res 1990;514:135-140.
11. Ban E, Milon G, Prudhomme N, Fillion G, Haour F: Receptors for interleukin-1 (a and b) in mouse brain: Mapping and neuronal localization in hippocampus. Neuroscience 1991; 43:21-30.
12. Cunningham ET Jr, Wada E, Carter DB, Tracey DE, Battey JF, De Souza EB: In situ histochemical localization of type 1 interleukin-1 receptor messenger RNA in the central nervous system, pituitary and adrenal gland of the mouse. J Neurosci 1992;12:1101-1114.
13. Parnet P, Amindari S, Wu C, Brunke-Reese D, Goujon E, Weyhenmeyer JA, Danzer R, Kelley KW: Expression of type I and type II interleukin-1 receptor in mouse brain. Mol Brain Res 1994;27:63-70.
14. Ericsson A, Liu C, Hart RP, Sawchenko PF: Type I interleukin-1 receptor in the rat brain. Distribution, regulation and relationship to sites of IL-1-induced cellular activation. J Comp Neurol 1995;361:681-698.
15. Cunningham AJ, Murray CA, O'Neill LAJ, Lynch MA, O'Connor JJ: Interleukin-1β (1L-1β) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci Letts 1996;203:1-4.
16. Rada P, Mark GP, Vitek MP, Manage RM, Blume AJ, Beer B, Hoebel BG: Interleukin-1β decreases acetylcholine measured by microdialysis in the hippocampus of freely moving rats. Brain Res 1991;550:287-290.
17. Murray CA, McGahon B, McBennett S, Lynch MA: Interleukin-1β inhibits glutamate release in hippocampus of young, but not aged rats. Neurobiol Aging 1997;18:343-348.
18. 2+ channel currents in hippocampal neurons through protein kinase C. Eur J Pharmacol 1994;266:1-10.
19. Lynch MA, Voss KL: Membrane arachidonic acid concentration correlates with age and induction of long-term potentiation in the dentate gyrus of the rat. Eur J Neurosci 1994;6: 1008-1014.
20. Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-358.
21. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of protein dye binding. Anal Biochem 1976;72:248-254.
22. Lebel CP, Bondy SC: Sensitive and rapid quantitation of oxygen reactive species formation in rat synaptosomes. Neurochem Int 1990;17: 435-440.
23. Miwa H, Yamamoto M, Nishida T: Assay of free and total fatty acids (as 2-nitrophenylhydrazides) by high performance liquid chromatography. Clin Chim Acta 1986;155:95-102.
24. Takao T, Tracey DE, Mitchell WM, De Souza EB: Interleukin-1 receptors in mouse brain: characterization and neuronal localization. Endocrinology 1990;127:3070-3078.
25. Horuk R, McCumbrey JA: The interleukin-1 receptor in Raji human B-lymphoma cells. Biochem J 1989;260:657-663.
26. Licinio J, Wong M-L, Gold PW: Localization of interleukin-1 receptor antagonist mRNA in rat brain. Endocrinology 1991;129:562-564.
27. Minami M, Kuraishi Y, Yamaguchi T, Nakai S, Hirai Y, Sato M: Convulsants induce interleukin-1β messenger RNA in rat brain. Biochem Biophys Res Commun 1990;171:832-837.
28. Dinarello CA: The biology of interleukin-1; in Kishimoto T (ed): Interleukins: Molecular Biology and Immunology. Chem Immunol. Basel, Karger, 1992, vol 51, p 1.
29. Rothwell NJ, Relton JK: Involvement of interleukin-1 and lipocortin-1 in ischemic brain damage. Cerebrovasc Brain Metab Rev 1993;5: 178-198.
30. A receptor function in brain. Mol Pharmacol 1991;39:105-108.
31. Nathan CF, Tsunawaki S: Secretion of toxic oxygen products by macrophages: Regulatory cytokines and their effects on the oxidase. Ciba Found Symp 1986;118:211-230.
32. Sumoski W, Baquerizo H, Rabinovitch A: Oxygen free radical scavengers protect ral islet cells from damage by cytokines. Diabetologia 1989; 32:792-796.
33. Ezirik D: Interleukin-1 impairment in pancreatic islet oxidative metabolism of glucose is potentiated by tumour necrosis factor. Acta Endocrinol (Copenh) 1988;119:321-325.
34. Harrison KA, Murphy RC: Isoleukotrienes are biologically active free radical products of lipid peroxidation. J Biol Chem 1995;270:17273-17278.
35. Olanow CW: A radical hypothesis for neurodegeneration. Trends Neurosci 1993;16:439-444.
36. Bertoni-Freddari C, Fattoretti P, Caselli U, Paoloni R, Meier-Ruge W: Vitamin E deficiency as a model of precocious aging: Assessment by X-ray microanalysis and morphometry. Scanning Microsc 1995;9:289-302.
37. Gupta A, Hasan M, Chandler R, Kapoor NK: Age-related elevation of lipid peroxidation products: Diminution of Superoxide dismutase activity in the central nervous system of rats. Gerontology 1991;37:305-309.
38. Vatassery GT: Vitamin E: Neurochemistry and implications for neurodegeneration in Parkinson's disease. Ann NY Acad Sci 1992;669:97-110.
39. Sharma D, Maurya AK, Singh R: Age-related decline in multiple unit action potential of CA3 region of rat hippocampus: Correlation with lipid peroxidalion and lipofuscin concentration and the effect of centrophenoxine. Neurobiol Aging 1993;14:319-330.
40. Cini M, Moretti A: Studies on lipid peroxidation and protein oxidation in the aging brain. Neurobiol Aging 1995;16:53-57.
41. Gutteridge JMC, Halliwell B: The measurement and mechanism of lipid peroxidation in biological systems. Trends Neurosci 1990;15: 129-135.
42. Choi JH, Yu BP: Brain synaptosomal aging: Free radicals and membrane fluidity. Free Radic Biol Med 1995;18:133-139.